[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@DalvinVarnado "@JD4for4 @VeracityRoad FDA requires follow up trials after expedited approval. Unmet need doesnt forgo ultra high standards around drug development that carry on INSIDER buying signals better XXX data than consensusmoney isnt going on drug crawling to phase X $NVCT"
@DalvinVarnado on X 2025-07-26 16:22:00 UTC 27.9K followers, XX engagements

"$NVCT major upside surprise coming. Predicting little talked about NXP800 with fast track status advancing to phase X with much better than expected trial data Recent insider buying what else can I say $AXSM $LLY $KYMR $RVMD $MRK"
@DalvinVarnado on X 2025-07-10 13:39:05 UTC 27.9K followers, 1628 engagements

"$NVCT delayed data NXP800 ongoing. Opposite universal low expectations Im expecting major rising stock price with data release showing tumor shrinkage 75mg intermittent dosing. Sets up free-roll on NXP900 a drug many investors think has blockbuster potential $AXSM $LLY $MRK $PFE"
@DalvinVarnado on X 2025-07-23 14:39:36 UTC 27.9K followers, 1288 engagements

"@JD4for4 $NVCT company said recent offering Feb XX provided runway into 2027. Was my opinion company would go back to market at higher price after XXX data. Recent insider buying and and now imo company letting someone close get a great entry price before XXX data. JUST THAT SIMPLE imo"
@DalvinVarnado on X 2025-07-25 13:17:00 UTC 27.9K followers, XXX engagements

"@VeracityRoad Yes during Nov XX update CEO said trial was currently enrolling last cohort of patients and would provide update during Q2. More recently about X months ago CEO pushed out timeline X months so data release is any day now past original timeline of Q2"
@DalvinVarnado on X 2025-07-23 17:21:03 UTC 27.9K followers, XX engagements